CDKN2A and hepatocellular carcinoma: Levels of other senescence biomarkers, including p16, p14, p27, p21 and p53, were also increased in hepatoma cells after these treatments (Figure 1G), suggesting p16/pRb and p14/p53 pathways are activated during ROS stress‐induced cellular senescence.